Vincerx Pharma, Inc. Other Income and Expense
Vincerx Pharma, Inc. reported Other Income and Expense of -$1.67 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2025-05-15
- Vincerx Pharma, Inc. nonoperating income (expense) for the quarter ending 2025-03-31 was -$1.67M.
- Vincerx Pharma, Inc. nonoperating income (expense) for the quarter ending 2024-12-31 was $832.00K, a 42.71% increase year-over-year.
- Vincerx Pharma, Inc. nonoperating income (expense) for the quarter ending 2024-09-30 was -$50.00K, a 108.31% decline year-over-year.
- Vincerx Pharma, Inc. nonoperating income (expense) for the quarter ending 2024-06-30 was $5.56M, a 991.94% increase year-over-year.
- Vincerx Pharma, Inc. nonoperating income (expense) for fiscal 2024 was $1.39M, a 43.35% decline from fiscal 2023.
- Vincerx Pharma, Inc. nonoperating income (expense) for fiscal 2023 was $2.45M, a 70.12% decline from fiscal 2022.
- Vincerx Pharma, Inc. nonoperating income (expense) for fiscal 2022 was $8.21M, a 64.85% decline from fiscal 2021.
- Vincerx Pharma, Inc. nonoperating income (expense) for fiscal 2021 was $23.35M.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month | Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-03-31 | -$1.67M 10-Q · filed 2025-05-15 | -$834.00K derived: sum of 2 quarters · filed 2025-05-15 | -$884.00K derived: sum of 3 quarters · filed 2025-05-15 | $4.67M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2024-12-31 | $832.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $782.00K derived: sum of 2 quarters · filed 2025-03-27 | $6.34M derived: sum of 3 quarters · filed 2025-03-27 | $1.39M 10-K · filed 2025-03-27 | |
| 2024-09-30 | -$50.00K 10-Q · filed 2024-11-12 | $5.51M derived: sum of 2 quarters · filed 2024-11-12 | $557.00K 10-Q · filed 2024-11-12 | $1.14M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2024-06-30 | $5.56M 10-Q · filed 2024-08-08 | $607.00K 10-Q · filed 2024-08-08 | $1.19M derived: sum of 3 quarters · filed 2025-05-15 | $1.79M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2024-03-31 | -$4.95M 10-Q · filed 2025-05-15 | -$4.37M derived: sum of 2 quarters · filed 2025-05-15 | -$3.77M derived: sum of 3 quarters · filed 2025-05-15 | -$3.26M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.19M derived: sum of 2 quarters · filed 2025-03-27 | $1.69M derived: sum of 3 quarters · filed 2025-03-27 | $2.45M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $602.00K 10-Q · filed 2024-11-12 | $1.11M derived: sum of 2 quarters · filed 2024-11-12 | $1.87M 10-Q · filed 2024-11-12 | $3.65M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $509.00K 10-Q · filed 2024-08-08 | $1.27M 10-Q · filed 2024-08-08 | $3.05M derived: sum of 3 quarters · filed 2024-08-08 | $3.07M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $758.00K 10-Q · filed 2024-05-14 | $2.54M derived: sum of 2 quarters · filed 2024-05-14 | $2.56M derived: sum of 3 quarters · filed 2024-05-14 | $3.76M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.80M derived: sum of 2 quarters · filed 2024-03-29 | $3.00M derived: sum of 3 quarters · filed 2024-03-29 | $8.21M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $22.00K 10-Q · filed 2023-11-14 | $1.22M derived: sum of 2 quarters · filed 2023-11-14 | $6.43M 10-Q · filed 2023-11-14 | $17.66M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $1.20M 10-Q · filed 2023-08-07 | $6.41M 10-Q · filed 2023-08-07 | $17.64M derived: sum of 3 quarters · filed 2023-08-07 | $11.05M derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | $5.20M 10-Q · filed 2023-05-11 | $16.44M derived: sum of 2 quarters · filed 2023-05-11 | $9.85M derived: sum of 3 quarters · filed 2023-05-11 | $25.20M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $11.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $4.64M derived: sum of 2 quarters · filed 2023-03-28 | $20.00M derived: sum of 3 quarters · filed 2023-03-28 | $23.35M 10-K · filed 2023-03-28 | |
| 2021-09-30 | -$6.59M 10-Q · filed 2022-11-10 | $8.77M derived: sum of 2 quarters · filed 2022-11-10 | $12.12M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $15.36M 10-Q · filed 2022-08-11 | $18.71M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $3.35M 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | -$5.91M 10-K · filed 2022-03-29 | -$8.00K 10-K · filed 2021-03-22 |